Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,495,430
+$2,454,610 QoQ
Shares Held
10,195
+2812.9% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#216
of 503 holders
Holding Since
Sep 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Neo Ivy Capital Management holds $15,852,316 across 14 Biotechnology names. AXSM ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
35,826 | $4,194,149 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
This page
|
10,195 | $2,495,430 | |
| 3 | VERA |
Vera Therapeutics, Inc.
|
48,937 | $2,099,886 | |
| 4 | IMNM |
Immunome Inc.
|
80,876 | $1,713,762 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
9,798 | $1,300,488 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
14,551 | $1,291,837 | |
| 7 | TECH |
BIO-TECHNE Corp
|
11,316 | $799,475 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
31,440 | $698,282 |
All Filings in AXSM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,495,430 | 10,195 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $40,820 | 350 | Shares | Sole | 2025-05-06 | |
| 2023-09-30 | $203,519 | 2,912 | Shares | Sole | 2023-11-30 | |
| 2022-09-30 | $10,039 | 225 | Shares | Sole | 2022-11-16 | |
| 2020-09-30 | $67,687 | 950 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||